1. Home
  2. VRT vs REGN Comparison

VRT vs REGN Comparison

Compare VRT & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertiv Holdings LLC

VRT

Vertiv Holdings LLC

N/A

Current Price

$149.48

Market Cap

73.2B

Sector

Technology

ML Signal

N/A

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

N/A

Current Price

$751.73

Market Cap

73.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRT
REGN
Founded
N/A
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.2B
73.9B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
VRT
REGN
Price
$149.48
$751.73
Analyst Decision
Buy
Buy
Analyst Count
18
23
Target Price
$188.13
$795.74
AVG Volume (30 Days)
7.3M
1.1M
Earning Date
10-22-2025
02-03-2026
Dividend Yield
0.16%
0.47%
EPS Growth
77.20
2.88
EPS
2.65
41.59
Revenue
$9,696,300,000.00
$14,247,800,000.00
Revenue This Year
$28.77
$1.95
Revenue Next Year
$19.97
$5.47
P/E Ratio
$60.58
$17.94
Revenue Growth
28.75
2.89
52 Week Low
$53.60
$476.49
52 Week High
$202.45
$790.98

Technical Indicators

Market Signals
Indicator
VRT
REGN
Relative Strength Index (RSI) 33.83 60.13
Support Level $159.82 $734.72
Resistance Level $185.41 $757.35
Average True Range (ATR) 8.88 19.59
MACD -3.05 -2.93
Stochastic Oscillator 4.71 61.46

Price Performance

Historical Comparison
VRT
REGN

About VRT Vertiv Holdings LLC

Vertiv has roots tracing back to 1946 when its founder, Ralph Liebert, developed an air-cooling system for mainframe data rooms. As computers started making their way into commercial applications in 1965, Liebert developed one of the first computer room air conditioning, or CRAC, units, enabling the precise control of temperature and humidity. The firm has slowly expanded its data center portfolio through internal product development and the acquisition of thermal and power management products like condensers, busways, and switches. Vertiv has global operations today; its products can be found in data centers in most regions throughout the world.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Share on Social Networks: